Withdrawn trial sought to Re-Sensitize tough colon cancers to treatment
NCT ID NCT04031872
Summary
This study was designed to test a new two-drug combination for people with advanced colorectal cancer that had stopped responding to standard chemotherapy. The goal was to see if adding an experimental drug (LY3200882) to an existing chemotherapy pill (capecitabine) could help control tumor growth again. The trial was intended for patients whose tumors had a specific genetic signature, but it was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.